These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


865 related items for PubMed ID: 26984187

  • 1. Alterations in the hypothalamic melanocortin pathway in amyotrophic lateral sclerosis.
    Vercruysse P, Sinniger J, El Oussini H, Scekic-Zahirovic J, Dieterlé S, Dengler R, Meyer T, Zierz S, Kassubek J, Fischer W, Dreyhaupt J, Grehl T, Hermann A, Grosskreutz J, Witting A, Van Den Bosch L, Spreux-Varoquaux O, GERP ALS Study Group, Ludolph AC, Dupuis L.
    Brain; 2016 Apr; 139(Pt 4):1106-22. PubMed ID: 26984187
    [Abstract] [Full Text] [Related]

  • 2. Activation of STAT3 and inhibitory effects of pioglitazone on STAT3 activity in a mouse model of SOD1-mutated amyotrophic lateral sclerosis.
    Shibata N, Yamamoto T, Hiroi A, Omi Y, Kato Y, Kobayashi M.
    Neuropathology; 2010 Aug; 30(4):353-60. PubMed ID: 19925559
    [Abstract] [Full Text] [Related]

  • 3. Effects of the PPARgamma activator pioglitazone on p38 MAP kinase and IkappaBalpha in the spinal cord of a transgenic mouse model of amyotrophic lateral sclerosis.
    Shibata N, Kawaguchi-Niida M, Yamamoto T, Toi S, Hirano A, Kobayashi M.
    Neuropathology; 2008 Aug; 28(4):387-98. PubMed ID: 18312546
    [Abstract] [Full Text] [Related]

  • 4. System xC- is a mediator of microglial function and its deletion slows symptoms in amyotrophic lateral sclerosis mice.
    Mesci P, Zaïdi S, Lobsiger CS, Millecamps S, Escartin C, Seilhean D, Sato H, Mallat M, Boillée S.
    Brain; 2015 Jan; 138(Pt 1):53-68. PubMed ID: 25384799
    [Abstract] [Full Text] [Related]

  • 5. Trehalose decreases mutant SOD1 expression and alleviates motor deficiency in early but not end-stage amyotrophic lateral sclerosis in a SOD1-G93A mouse model.
    Li Y, Guo Y, Wang X, Yu X, Duan W, Hong K, Wang J, Han H, Li C.
    Neuroscience; 2015 Jul 09; 298():12-25. PubMed ID: 25841320
    [Abstract] [Full Text] [Related]

  • 6. Loss of hypothalamic MCH decreases food intake in amyotrophic lateral sclerosis.
    Bolborea M, Vercruysse P, Daria T, Reiners JC, Alami NO, Guillot SJ, Dieterlé S, Sinniger J, Scekic-Zahirovic J, Londo A, Arcay H, Goy MA, de Tapia CN, Thal DR, Shibuya K, Otani R, Arai K, Kuwabara S, Ludolph AC, Roselli F, Yilmazer-Hanke D, Dupuis L.
    Acta Neuropathol; 2023 Jun 09; 145(6):773-791. PubMed ID: 37058170
    [Abstract] [Full Text] [Related]

  • 7. Knocking down metabotropic glutamate receptor 1 improves survival and disease progression in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Milanese M, Giribaldi F, Melone M, Bonifacino T, Musante I, Carminati E, Rossi PI, Vergani L, Voci A, Conti F, Puliti A, Bonanno G.
    Neurobiol Dis; 2014 Apr 09; 64():48-59. PubMed ID: 24361555
    [Abstract] [Full Text] [Related]

  • 8. Hypoxia causes autophagic stress and derangement of metabolic adaptation in a cell model of amyotrophic lateral sclerosis.
    Cimini S, Rizzardini M, Biella G, Cantoni L.
    J Neurochem; 2014 May 09; 129(3):413-25. PubMed ID: 24359187
    [Abstract] [Full Text] [Related]

  • 9. Over-expression of Hsp27 does not influence disease in the mutant SOD1(G93A) mouse model of amyotrophic lateral sclerosis.
    Krishnan J, Vannuvel K, Andries M, Waelkens E, Robberecht W, Van Den Bosch L.
    J Neurochem; 2008 Sep 09; 106(5):2170-83. PubMed ID: 18624915
    [Abstract] [Full Text] [Related]

  • 10. The oral antidiabetic pioglitazone protects from neurodegeneration and amyotrophic lateral sclerosis-like symptoms in superoxide dismutase-G93A transgenic mice.
    Schütz B, Reimann J, Dumitrescu-Ozimek L, Kappes-Horn K, Landreth GE, Schürmann B, Zimmer A, Heneka MT.
    J Neurosci; 2005 Aug 24; 25(34):7805-12. PubMed ID: 16120782
    [Abstract] [Full Text] [Related]

  • 11. Methylene blue administration fails to confer neuroprotection in two amyotrophic lateral sclerosis mouse models.
    Audet JN, Soucy G, Julien JP.
    Neuroscience; 2012 May 03; 209():136-43. PubMed ID: 22230045
    [Abstract] [Full Text] [Related]

  • 12. A mouse model of familial amyotrophic lateral sclerosis expressing a mutant superoxide dismutase 1 shows evidence of disordered transport in the vasopressin hypothalamo-neurohypophysial axis.
    González de Aguilar JL, Gordon JW, René F, Lutz-Bucher B, Kienlen-Campard P, Loeffler JP.
    Eur J Neurosci; 1999 Dec 03; 11(12):4179-87. PubMed ID: 10594643
    [Abstract] [Full Text] [Related]

  • 13. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model.
    Zhao Z, Sui Y, Gao W, Cai B, Fan D.
    J Int Med Res; 2015 Feb 03; 43(1):67-79. PubMed ID: 25534414
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Genetic ablation of phospholipase C delta 1 increases survival in SOD1(G93A) mice.
    Staats KA, Van Helleputte L, Jones AR, Bento-Abreu A, Van Hoecke A, Shatunov A, Simpson CL, Lemmens R, Jaspers T, Fukami K, Nakamura Y, Brown RH, Van Damme P, Liston A, Robberecht W, Al-Chalabi A, Van Den Bosch L.
    Neurobiol Dis; 2013 Dec 03; 60():11-7. PubMed ID: 23969236
    [Abstract] [Full Text] [Related]

  • 16. Overexpression of metallothionein-I, a copper-regulating protein, attenuates intracellular copper dyshomeostasis and extends lifespan in a mouse model of amyotrophic lateral sclerosis caused by mutant superoxide dismutase-1.
    Tokuda E, Okawa E, Watanabe S, Ono S.
    Hum Mol Genet; 2014 Mar 01; 23(5):1271-85. PubMed ID: 24163136
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. TDP-43 physically interacts with amyotrophic lateral sclerosis-linked mutant CuZn superoxide dismutase.
    Higashi S, Tsuchiya Y, Araki T, Wada K, Kabuta T.
    Neurochem Int; 2010 Dec 01; 57(8):906-13. PubMed ID: 20933032
    [Abstract] [Full Text] [Related]

  • 19. Up-regulation of mitochondrial uncoupling protein 3 reveals an early muscular metabolic defect in amyotrophic lateral sclerosis.
    Dupuis L, di Scala F, Rene F, de Tapia M, Oudart H, Pradat PF, Meininger V, Loeffler JP.
    FASEB J; 2003 Nov 01; 17(14):2091-3. PubMed ID: 14500553
    [Abstract] [Full Text] [Related]

  • 20. Histological evidence of protein aggregation in mutant SOD1 transgenic mice and in amyotrophic lateral sclerosis neural tissues.
    Watanabe M, Dykes-Hoberg M, Culotta VC, Price DL, Wong PC, Rothstein JD.
    Neurobiol Dis; 2001 Dec 01; 8(6):933-41. PubMed ID: 11741389
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 44.